Delivery Order SPE2DB22D3501-SPE2DB25FWU52
- Not listed
- The Defense Logistics Agency awarded a $4,276.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Qualiptia 60 mg on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $3,533.99 to AmerisourceBergen Drug Corp for Qualtipta 60 mg tablets (30-count) on July 28, 2025, with performance through July 29, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at approximately $20,000 to AmerisourceBergen Drug Corp for the supply of Qualipta 60 mg tablets (30-count units). The contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing...
- The Defense Logistics Agency awarded a delivery order valued at $1,157.61 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qualiptia 60 mg tablets in a quantity of 30 units. This contract, which is a non-set-aside award issued under firm fixed pricing, is scheduled for completion by July 31, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award to AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,547.07 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a $3,372.82 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,337.55 to AmerisourceBergen Drug Corp for the supply of Qualiptа 30 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,147.37 to AmerisourceBergen Drug Corp for the supply of Qualiptia 60 mg tablets (30-count packaging) under a firm fixed price contract. This non-competitive delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a routine pharmaceutical procurement from the vendor's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1.75K to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) with a firm fixed price structure. This non-competitive delivery order, issued on August 1, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 4, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,373.74 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the DLA's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWU52Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,311.24 to AmerisourceBergen Drug Corp for the supply of Qualupta 60 mg tablets (quantity 30) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and healthcare systems, leveraging its comprehensive IDC vehicle to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide. This delivery order for Qualupta, a medication used in psychiatric treatment, exemplifies the company's role in fulfilling routine pharmaceutical procurement requirements for the military medical supply chain through the DLA's flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/11/25 |